Change in the number of votes relating to Biotie Therapies Corp.'s shares


BIOTIE THERAPIES CORP.                  Stock Exchange Release            27
February 2015 at 8.50 am

Change in the number of votes relating to Biotie Therapies Corp.'s shares

Biotie Therapies Corp. ("Biotie" or the "Company") has conveyed Biotie shares
held as treasury shares, that were issued on 17 December 2014, pursuant to the
Stock Option Plan 2011 and the Equity Incentive Plan 2011 (the "Plans") as
follows:

 Shares   Cumulative shares Remaining shares
 conveyed  conveyed since   to be conveyed
          17 December 2014

  267,500 1,276,875         1,170,500

Under the Stock Option Plan 2011, the owners of the stock options may subscribe
for a maximum total of 7,401,000 new shares in the Company or existing shares
held by the Company, of which a total of 1,844,250 were subscribed for in 2014.
A total of 130,000 shares have been subscribed for during the period 20 January
2015 and 19 February 2015 and 130,000 of the treasury shares will be used for
these share subscriptions. The subscription price of EUR 0.01 per share has been
fully paid by the employee and the EUR 1,300 funds received will be credited to
the Company's reserve for non-restricted equity. Due to share issues already
made pursuant to the Stock Option Plan 2011, forfeitures and some of the
instruments based on the plan having been left unallocated, a maximum of
2,950,500 shares may still be issued pursuant to the Stock Option Plan 2011.

The second vesting period of the Equity Incentive Plan 2011 ended on 5 January
2015, after which the Company's shares shall be delivered to employees on the
basis of the granted share units. It was resolved pursuant to the authorization
of the Annual General Meeting of the Shareholders held on 3 April 2014 to issue
137,500 existing treasury shares to the employees without consideration for the
purposes of remunerating the employees pursuant to the terms and conditions of
the Equity Incentive Plan 2011 and thus, there is an especially weighty
financial reason to derogate from the pre-emptive right of the shareholders, as
referred to in Chapter 9 Section 4(1) of the Companies Act (624/2006, as
amended). Due to share issues already made pursuant to the Equity Incentive Plan
2011, forfeitures and some of the instruments based on the plan having been left
unallocated, a maximum of 1,245,000 shares may still be issued pursuant to the
Equity Incentive Plan 2011.

The conveyed shares previously held as treasury shares have not carried any
voting rights. The conveyance does not affect the number of registered shares.
After the conveyances the changes are as follows:

 Increase in number Total amount of Number of the    Total number
 of outstanding     voting rights   Company's shares of registered
 shares                             held by          shares
                                    the Group

 267,500            451,972,890     3,995,284        455,968,174




Turku, 27 February 2015

Biotie Therapies Corp.
Timo Veromaa, President and CEO

For further information, please contact:
Virve Nurmi, Investor Relations Manager, Biotie Therapies Corp.
tel. +358 2 274 8900, e-mail: virve.nurmi@biotie.com
www.biotie.com

DISTRIBUTION:
NASDAQ OMX Helsinki Ltd
Main Media




[HUG#1897894]